JOHN W KOZARICH Insider Trading $LGND LIGAND PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN W KOZARICH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN W KOZARICH. JOHN W KOZARICH is Director in LIGAND PHARMACEUTICALS INC ($LGND) and Director in QLT INC/BC ($QLTI) and Director in Retrophin, Inc. ($RTRX) and Director in Intec Pharma Ltd. ($NTEC).
JOHN W KOZARICH in LIGAND PHARMACEUTICALS INC
Trading Symbol: LGNDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN W KOZARICH: Director
Holdings: 34,543 shares
Current Value: $3,725,117
Latest Transaction: May 13 2021
$LGND Market Capitalization: $2.24B
$LGND Previous Close: $107.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN W KOZARICH in LIGAND PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, NTEC, LGND, NVLN, RTRX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | M | 10.12 | 4,835 | 48,930 | 0 | |
May 13 2021 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Payment of Exercise | F | 128.56 | 391 | 50,267 | 34,152 | 34.5 K to 34.2 K (-1.13 %) |
May 13 2021 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Buy | M | 10.12 | 4,835 | 48,930 | 34,543 | 29.7 K to 34.5 K (+16.28 %) |
Feb 23 2021 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | M | 10.12 | 2,500 | 25,300 | 4,835 | |
Feb 23 2021 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Buy | M | 10.12 | 2,500 | 25,300 | 29,708 | 27.2 K to 29.7 K (+9.19 %) |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 117.58 | 2,468 | 290,187 | 2,468 | |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 0.00 | 831 | 0 | 27,208 | 26.4 K to 27.2 K (+3.15 %) |
Jun 07 2019 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 113.59 | 4,071 | 462,425 | 4,071 | |
Jun 07 2019 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 0.00 | 835 | 0 | 26,377 | 25.5 K to 26.4 K (+3.27 %) |
May 14 2019 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | M | 17.88 | 2,500 | 44,700 | 0 | |
May 14 2019 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 112.92 | 2,500 | 282,300 | 25,542 | 28 K to 25.5 K (-8.92 %) |
May 14 2019 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Buy | M | 17.88 | 2,500 | 44,700 | 28,042 | 25.5 K to 28 K (+9.79 %) |
Oct 02 2018 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 275.04 | 2,500 | 687,610 | 26,142 | 28.6 K to 26.1 K (-8.73 %) |
Jul 03 2018 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 207.48 | 2,500 | 518,699 | 28,642 | 31.1 K to 28.6 K (-8.03 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 0.00 | 493 | 0 | 31,142 | 30.6 K to 31.1 K (+1.61 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 0.00 | 493 | 0 | 31,142 | 30.6 K to 31.1 K (+1.61 %) |
Apr 03 2018 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 160.43 | 2,500 | 401,063 | 30,649 | 33.1 K to 30.6 K (-7.54 %) |
Jan 11 2018 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 145.00 | 2,500 | 362,500 | 33,149 | 35.6 K to 33.1 K (-7.01 %) |
Nov 17 2017 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 141.71 | 5,000 | 708,550 | 35,649 | 40.6 K to 35.6 K (-12.30 %) |
May 26 2017 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 113.50 | 2,456 | 278,756 | 2,456 | |
May 26 2017 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 0.00 | 666 | 0 | 40,649 | 40 K to 40.6 K (+1.67 %) |
Sep 09 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 115.00 | 1,000 | 115,000 | 39,983 | 41 K to 40 K (-2.44 %) |
Sep 06 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 106.87 | 200 | 21,373 | 39,317 | 39.5 K to 39.3 K (-0.51 %) |
Sep 06 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 105.82 | 866 | 91,643 | 39,517 | 40.4 K to 39.5 K (-2.14 %) |
Sep 06 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 104.66 | 400 | 41,863 | 40,383 | 40.8 K to 40.4 K (-0.98 %) |
Sep 06 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 103.59 | 200 | 20,718 | 40,783 | 41 K to 40.8 K (-0.49 %) |
Aug 02 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 139.51 | 100 | 13,951 | 40,983 | 41.1 K to 41 K (-0.24 %) |
Aug 02 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 138.31 | 200 | 27,662 | 41,083 | 41.3 K to 41.1 K (-0.48 %) |
Aug 02 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 137.60 | 500 | 68,800 | 41,283 | 41.8 K to 41.3 K (-1.20 %) |
Aug 02 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 135.78 | 200 | 27,156 | 41,783 | 42 K to 41.8 K (-0.48 %) |
Jul 05 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 122.23 | 100 | 12,223 | 41,983 | 42.1 K to 42 K (-0.24 %) |
Jul 05 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 121.54 | 800 | 97,232 | 42,083 | 42.9 K to 42.1 K (-1.87 %) |
Jul 05 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 119.47 | 100 | 11,947 | 42,883 | 43 K to 42.9 K (-0.23 %) |
Jun 03 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 119.48 | 100 | 11,948 | 42,983 | 43.1 K to 43 K (-0.23 %) |
Jun 03 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 117.19 | 900 | 105,471 | 43,083 | 44 K to 43.1 K (-2.05 %) |
Jun 03 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Gift | G | 0.00 | 350 | 0 | 43,361 | 43.7 K to 43.4 K (-0.80 %) |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 119.30 | 2,329 | 277,850 | 2,329 | |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 0.00 | 622 | 0 | 44,333 | 43.7 K to 44.3 K (+1.42 %) |
May 03 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 122.04 | 200 | 24,408 | 43,711 | 43.9 K to 43.7 K (-0.46 %) |
May 03 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 121.45 | 800 | 97,160 | 43,911 | 44.7 K to 43.9 K (-1.79 %) |
Apr 07 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 115.00 | 5,000 | 575,000 | 44,711 | 49.7 K to 44.7 K (-10.06 %) |
Jan 22 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | M | 59.40 | 1,666 | 98,960 | 0 | |
Jan 22 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 97.99 | 366 | 35,864 | 49,711 | 50.1 K to 49.7 K (-0.73 %) |
Jan 22 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 96.28 | 200 | 19,256 | 50,077 | 50.3 K to 50.1 K (-0.40 %) |
Jan 22 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 94.71 | 200 | 18,942 | 50,277 | 50.5 K to 50.3 K (-0.40 %) |
Jan 22 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 93.83 | 600 | 56,298 | 50,477 | 51.1 K to 50.5 K (-1.17 %) |
Jan 22 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 92.71 | 300 | 27,813 | 51,077 | 51.4 K to 51.1 K (-0.58 %) |
Jan 22 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Buy | M | 59.40 | 1,666 | 98,960 | 51,377 | 49.7 K to 51.4 K (+3.35 %) |
May 18 2015 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Gift | G | 0.00 | 500 | 0 | 49,711 | 50.2 K to 49.7 K (-1.00 %) |
Apr 27 2015 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 89.75 | 2,754 | 247,172 | 2,754 | |
Apr 27 2015 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 0.00 | 925 | 0 | 50,211 | 49.3 K to 50.2 K (+1.88 %) |
Jan 06 2004 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 4.98 | 2,763 | 13,749 | 2,763 |
Page: 1